What is Cerebrolysin?
Cerebrolysin is a low molecular weight, porcine-derived peptide with free amino acids. It has a variety of clinical applications due to its neuroprotective and neurotrophic properties. It is used as a neurotrophic agent for the treatment of ischemic stroke, brain trauma, and Alzheimer’s Disease. Cerebrolysin also known as FPE 1070. It consists of low-molecular peptides and possesses neuroprotective and neurotrophic repair properties. The active fragment of Cerebrolysin is made of low molecular proteins that can penetrate the blood-brain (or blood-SCF) barrier. Cerebrolysin has been proven to have neurotrophic action similar to nerve growth factors causing peripheral and central neuronal stimulation. It improves efficiency within the brain’s metabolism and improves cellular peptide synthesis. The neuroprotective properties of Cerebrolysin help to protect brain cells from lactic acid, reduce the formation of free radicals and to decrease the neurotoxicity of certain amino acids.
How Cerebrolysin Repairs and Improves the Brain
Neurotrophic factors are molecules that are responsible for growing, maintaining, and repairing neurons. They also have neuroprotective properties that strengthen neural pathways and the integrity of the neurons themselves. They are responsible for promoting synaptic plasticity, which is a way the brain strengthens certain neural pathways. In situations where the brain needs to utilize neurotrophic factors to repair damaged neurons, such as in the case of neurological disease, Cerebrolysin can be administered to act as an analog to endogenous neurotrophic factors. Studies have shown that the use of Cerebrolysin as treatment of neurodegenerative disease has often proved effective as a means of symptomatic treatment as well as pathological suppression in both the short and long term.
Additionally, due to its neuroprotective properties, Cerebrolysin has been shown to have the preventative potential for individuals who have a genetic predisposition to developing Alzheimer’s disease. Cerebrolysin’s neurotrophic effects may reduce the neurodegenerative pathology in Alzheimer’s disease (AD). It decreases amyloid burden but the mechanisms involved are not understood. Cerebrolysin might reduce amyloid deposition by regulating amyloid (Ab) degradation or by modulating APP expression, maturation, or processing.
While Cerebrolysin is not FDA approved in the United States, it is approved in many European and Asian countries for stroke, dementia, and traumatic brain injury.
At the Taylor Medical Wellness Group, we provide IV nutritional therapy in a relaxing spa-like environment. Listen to tranquil music, recline in a massage chair, lie on a relaxing infrared detox bed or watch your favorite movie during your IV wellness treatment. Your treatment will be provided by one of our doctors or nurses who will help you choose your perfect IV Therapy Treatment personalized to your health’s needs today!
Call 678-443-4000 for more information and to book an appointment!
Wellness and Weight Loss
Hair Loss Treatment
Priapus Shot (P Shot)
GAINSWave ED Treatment
Male Hormone Replacement
Holistic Addiction Treatment